Evidence map›Paper›PMID 41695880›Full record

ArticleWorld journal of gastrointestinal surgery2026

Very early recurrence in pancreatic cancer: Redefining prognostic markers and surveillance strategies.

Riya Karmakar, Pratham Gade, Hsiang-Chen Wang, Arvind Mukundan

Abstract readEditorial
In one paragraph

Article in World journal of gastrointestinal surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Riya KarmakarDepartment of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan.
Pratham GadeDepartment of Information Technology, Sanjivani College of Engineering, Kopargaon 423603, Mahārāshtra, India.
Hsiang-Chen WangDepartment of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan.
Arvind MukundanDepartment of Mechanical Engineering, National Chung Cheng University, Chiayi 62102, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This editorial discusses the difficulties and challenges of managing pancreatic ductal adenocarcinoma. Approximately 50% of patients experience recurrence within one year after the curative-intent surgery as its highly lethal malignancy, the most sever outcome is very early recurrence (VER), which occurs within 12 weeks which reflects an aggressive tumor. The limitation of standards after surgery management in preventing VER, which significantly causes death in six-months (32.44%

Indexed as

Machine learningPancreatic ductal adenocarcinomaRed cell distribution widthTumorTumor locationVery early recurrence

Identifiers

PMID41695880
PMCPMC12898895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.